prof.dr. C. von Birgelen (Clemens)



Drug-Eluting Stents
Coronary Vessels
Percutaneous Coronary Intervention
Myocardial Infarction
Coronary Artery Disease


  • Medisch Spectrum Twente, Thoraxcentrum Twente, Enschede
    hoofdwerkzaamheid = cardioloog / interventiecardioloog


Asano, T., Katagiri, Y., Collet, C., Tenekecioglu, E., Miyazaki, Y., Sotomi, Y., ... Serruys, P. W. (2018). Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy. EuroIntervention, 14(5), e570-e579. DOI: 10.4244/EIJ-D-17-00461
Faggioni, M., Baber, U., Afshar, A. E., Giustino, G., Sartori, S., Sorrentino, S., ... Mehran, R. (2018). Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. JACC: Cardiovascular Interventions, 11(1), 68-76. DOI: 10.1016/j.jcin.2017.06.060
Garcia-Garcia, H. M., Haude, M., Kuku, K., Hideo-Kajita, A., Ince, H., Abizaid, A., ... Waksman, R. (2018). In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris — DREAMS 2G) in de novo coronary lesions: Insights from the BIOSOLVE-II First-In-Man Trial. International journal of cardiology, 255, 22-28. DOI: 10.1016/j.ijcard.2017.12.053
Wu, X., von Birgelen, C., Li, Z., Zhang, S., Huang, J., Liang, F., ... Tu, S. (2018). Assessment of superficial coronary vessel wall deformation and stress: validation of in silico models and human coronary arteries in vivo. International journal of cardiovascular imaging, 34(6), 849-861. DOI: 10.1007/s10554-018-1311-7
Palmerini, T., Della Riva, D., Biondi-Zoccai, G., Leon, M. B., Serruys, P. W., Smits, P. C., ... Stone, G. W. (2018). Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis of 21 Randomized Trials and 32,524 Patients. JACC: Cardiovascular Interventions, 11(9), 892-902. DOI: 10.1016/j.jcin.2018.01.277
Brener, S. J., Tarantini, G., Leon, M. B., Serruys, P. W., Smits, P. C., von Birgelen, C., ... Stone, G. W. (2018). Cardiovascular and Noncardiovascular Death After Percutaneous Coronary Intervention: Insights From 32882 Patients Enrolled in 21 Randomized Trials. Circulation : cardiovascular interventions, 11(7), [e006488]. DOI: 10.1161/CIRCINTERVENTIONS.118.006488
Haude, M., Ince, H., Kische, S., Abizaid, A., Tölg, R., Alves Lemos, P., ... Waksman, R. (2018). Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III. Catheterization and cardiovascular interventions. DOI: 10.1002/ccd.27680

Pure Link



Universiteit Twente
Drienerlolaan 5
7522 NB Enschede

Navigeer naar locatie


Universiteit Twente
Postbus 217
7500 AE Enschede